Cochlear (ASX:COH) - Prezzo delle azioni, notizie e analisi

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

COH Panoramica delle azioni

Cochlear Limited fornisce soluzioni uditive impiantabili per bambini e adulti in tutto il mondo.

COH analisi fondamentale
Punteggio fiocco di neve
Valutazione	1/6
Crescita futura	3/6
Prestazioni passate	4/6
Salute finanziaria	6/6
Dividendi	0/6

Premi

Si prevede che gli utili cresceranno del 11.47% all'anno

Gli utili sono cresciuti del 18.7% nell'ultimo anno

Analisi del rischio

Non sono stati rilevati rischi per COH dai nostri controlli di rischio.

Cochlear Limited Concorrenti

Pro Medicus

ASX:PME

AU$15.6b

Ramsay Health Care

ASX:RHC

AU$10.8b

Sonic Healthcare

ASX:SHL

AU$13.4b

Austco Healthcare

ASX:AHC

AU$79.4m

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per Cochlear
Prezzi storici delle azioni
Prezzo attuale dell'azione	AU$310.20
Massimo di 52 settimane	AU$350.31
Minimo di 52 settimane	AU$237.69
Beta	0.49
1Variazione di 1 mese	-4.20%
Variazione a 3 mesi	-2.16%
Variazione di 1 anno	16.55%
3Variazione a 3 anni	31.06%
Variazione a 5 anni	46.96%
Variazione dall'IPO	10,415.25%

Notizie e aggiornamenti recenti

Cochlear Limited Just Missed EPS By 7.4%: Here's What Analysts Think Will Happen Next

Aug 16

Investors Could Be Concerned With Cochlear's (ASX:COH) Returns On Capital

Aug 01

Recent updates

Cochlear Limited Just Missed EPS By 7.4%: Here's What Analysts Think Will Happen Next

Aug 16

Is Cochlear Limited (ASX:COH) Expensive For A Reason? A Look At Its Intrinsic Value

Oct 04

Cochlear (ASX:COH) Could Be Struggling To Allocate Capital

Sep 12

Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital

Jun 05

Cochlear (ASX:COH) Seems To Use Debt Quite Sensibly

Apr 05

Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital

Mar 04

Is Cochlear (ASX:COH) A Risky Investment?

Dec 19

Is Cochlear Limited (ASX:COH) Worth AU$205 Based On Its Intrinsic Value?

Nov 16

The Returns On Capital At Cochlear (ASX:COH) Don't Inspire Confidence

Oct 25

Should Shareholders Reconsider Cochlear Limited's (ASX:COH) CEO Compensation Package?

Oct 11

Cochlear's (ASX:COH) Upcoming Dividend Will Be Larger Than Last Year's

Aug 28

Here's Why Cochlear (ASX:COH) Can Manage Its Debt Responsibly

Aug 23

The Returns On Capital At Cochlear (ASX:COH) Don't Inspire Confidence

Jul 16

A Look At The Fair Value Of Cochlear Limited (ASX:COH)

May 19

Capital Allocation Trends At Cochlear (ASX:COH) Aren't Ideal

Apr 09

Estimating The Intrinsic Value Of Cochlear Limited (ASX:COH)

Feb 04

Capital Allocation Trends At Cochlear (ASX:COH) Aren't Ideal

Dec 24

Cochlear (ASX:COH) Seems To Use Debt Quite Sensibly

Oct 30

This Is Why We Think Cochlear Limited's (ASX:COH) CEO Might Get A Pay Rise Approved By Shareholders

Oct 12

A Look At The Fair Value Of Cochlear Limited (ASX:COH)

Oct 06

Returns On Capital Signal Tricky Times Ahead For Cochlear (ASX:COH)

Aug 16

Cochlear (ASX:COH) Has A Pretty Healthy Balance Sheet

Jun 24

A Look At The Intrinsic Value Of Cochlear Limited (ASX:COH)

May 17

There Are Reasons To Feel Uneasy About Cochlear's (ASX:COH) Returns On Capital

Apr 29

These 4 Measures Indicate That Cochlear (ASX:COH) Is Using Debt Reasonably Well

Mar 20

Insider Buying: The Cochlear Limited (ASX:COH) Independent Non-Executive Director Just Bought 24% More Shares

Mar 02

Cochlear Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Feb 20

Rendimenti per gli azionisti

	COH	AU Medical Equipment	AU Mercato
7D	-8.7%	-6.2%	2.2%
1Y	16.6%	11.3%	11.2%

Ritorno vs Industria: COH ha superato il Australian Medical Equipment che ha restituito 11.3 % nell'ultimo anno.

Rendimento vs Mercato: COH ha superato il mercato Australian che ha restituito 11.2 % nell'ultimo anno.

Volatilità dei prezzi

Is COH's price volatile compared to industry and market?
COH volatility
COH Average Weekly Movement	4.1%
Medical Equipment Industry Average Movement	10.1%
Market Average Movement	8.2%
10% most volatile stocks in AU Market	16.9%
10% least volatile stocks in AU Market	3.4%

Prezzo delle azioni stabile: COH non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi.

Volatilità nel tempo: La volatilità settimanale ( 4% ) di COH è rimasta stabile nell'ultimo anno.

Informazioni sull'azienda

Fondato	I dipendenti	AMMINISTRATORE DELEGATO	Sito web
1981	5,047	Dig Howitt	www.cochlear.com

Cochlear Limited fornisce soluzioni uditive impiantabili per bambini e adulti in tutto il mondo. Offre sistemi di impianti cocleari, aggiornamenti dell'elaboratore del suono, sistemi a conduzione ossea, accessori e altri prodotti. L'azienda è stata fondata nel 1981 e ha sede a Sydney, in Australia.

Cochlear Limited Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di Cochlear con la sua capitalizzazione di mercato?
COH statistiche fondamentali
Capitalizzazione di mercato	AU$20.14b
Guadagni(TTM)	AU$356.80m
Ricavi(TTM)	AU$2.24b

56.9x

Rapporto P/E

9.1x

Rapporto P/S

COH è sopravvalutato?

Vedi Fair Value e analisi di valutazione

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
COH Conto economico (TTM)
Ricavi	AU$2.24b
Costo del fatturato	AU$562.10m
Profitto lordo	AU$1.67b
Altre spese	AU$1.32b
Guadagni	AU$356.80m

Ultimi guadagni dichiarati

Jun 30, 2024

Prossima data di guadagno

Feb 14, 2025

Utile per azione (EPS)	5.45
Margine lordo	74.86%
Margine di profitto netto	15.96%
Rapporto debito/patrimonio netto	0%

Come si è comportato COH nel lungo periodo?

Vedi performance storica e confronto

Dividendi

1.4%

Rendimento attuale del dividendo

75%

Rapporto di remunerazione

COH paga dividendi affidabili?

Vedere la storia dei dividendi e i benchmark di COH

Quando è necessario acquistare COH per ricevere un dividendo imminente?
Cochlear date dei dividendi
Data di stacco del dividendo	Sep 17 2024
Data di pagamento dei dividendi	Oct 10 2024
Giorni fino al dividendo Ex	27 days
Giorni prima della data di pagamento dei dividendi	50 days

COH paga dividendi affidabili?

Vedere la storia dei dividendi e i benchmark di COH

COH Panoramica delle azioni

Premi

Analisi del rischio

Cochlear Limited Concorrenti

ASX:PME

AU$15.6b

ASX:RHC

AU$10.8b

ASX:SHL

AU$13.4b

ASX:AHC

AU$79.4m

Storia dei prezzi e prestazioni

Notizie e aggiornamenti recenti

Final dividend of AU$2.10 announced

Cochlear Limited Announces Ordinary Dividend for the Period of Six Months Ended June 30, 2024, Payable on October 10, 2024

Cochlear Limited Just Missed EPS By 7.4%: Here's What Analysts Think Will Happen Next

Full year 2024 earnings: EPS misses analyst expectations

Cochlear Limited (ASX:COH) announces an Equity Buyback for AUD 75 million worth of its shares.

Investors Could Be Concerned With Cochlear's (ASX:COH) Returns On Capital

Recent updates

Final dividend of AU$2.10 announced

Cochlear Limited Announces Ordinary Dividend for the Period of Six Months Ended June 30, 2024, Payable on October 10, 2024

Cochlear Limited Just Missed EPS By 7.4%: Here's What Analysts Think Will Happen Next

Full year 2024 earnings: EPS misses analyst expectations

Cochlear Limited (ASX:COH) announces an Equity Buyback for AUD 75 million worth of its shares.

Investors Could Be Concerned With Cochlear's (ASX:COH) Returns On Capital

Cochlear Limited Appoints Caroline Clarke as Non-Executive Director, Effective from 2 September 2024

Cochlear Limited Announces Executive Changes

Here's Why We Think Cochlear (ASX:COH) Is Well Worth Watching

Cochlear Limited (ASX:COH) acquired Oticon Medical A/s from Demant A/S (CPSE:DEMANT).

Cochlear Limited Announces Company Secretary Changes

Cochlear Limited Receives Fda Clearance to Lower the Age for the Osia System to 5-Year-Old

Cochlear (ASX:COH) Might Be Having Difficulty Using Its Capital Effectively

Upcoming dividend of AU$2.00 per share

First half dividend increased to AU$2.00

Here's Why We Think Cochlear (ASX:COH) Is Well Worth Watching

First half 2024 earnings: EPS in line with expectations, revenues disappoint

Price target increased by 7.0% to AU$272

Cochlear (ASX:COH) Might Be Having Difficulty Using Its Capital Effectively

Is Cochlear Limited (ASX:COH) Expensive For A Reason? A Look At Its Intrinsic Value

Cochlear (ASX:COH) Could Be Struggling To Allocate Capital

Upcoming dividend of AU$1.75 per share at 1.2% yield

Cochlear Limited Introduces Next Generation Cochlear Osia System with Ability to Have MRI at 3.0 T

Cochlear Limited to Report Fiscal Year 2024 Results on Aug 15, 2024

Full year 2023 earnings: EPS in line with analyst expectations despite revenue beat

Cochlear Limited Announces Andrew Denver, Non-Executive Director Intention to Retire At AGM to Be Held on 17 October 2023

Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital

Cochlear (ASX:COH) Seems To Use Debt Quite Sensibly

Upcoming dividend of AU$1.55 per share at 1.3% yield

Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital

Cochlear Limited Provides Earnings Outlook for the Year 2023

Cochlear Limited (ASX:COH) announces an Equity Buyback for AUD 75 million worth of its shares.

Is Cochlear (ASX:COH) A Risky Investment?

Cochlear Limited, Annual General Meeting, Oct 17, 2023

Is Cochlear Limited (ASX:COH) Worth AU$205 Based On Its Intrinsic Value?

FDA Approves Cochlear Limited's Nucleus 8 Sound Processor, Smaller, Smarter, Better Connected Cochlear Implant Technology

Key Executive recently bought AU$97k worth of stock

The Returns On Capital At Cochlear (ASX:COH) Don't Inspire Confidence

Should Shareholders Reconsider Cochlear Limited's (ASX:COH) CEO Compensation Package?

Upcoming dividend of AU$1.45 per share

Cochlear's (ASX:COH) Upcoming Dividend Will Be Larger Than Last Year's

Here's Why Cochlear (ASX:COH) Can Manage Its Debt Responsibly

Full year 2022 earnings: EPS misses analyst expectations

Cochlear Announces Final Dividend Payable on 17 October 2022

The Returns On Capital At Cochlear (ASX:COH) Don't Inspire Confidence

Cochlear Limited Appoints Karen Penrose to Board, Effective on 1 July 2022

A Look At The Fair Value Of Cochlear Limited (ASX:COH)

Cochlear Limited, Annual General Meeting, Oct 18, 2022

Cochlear Limited to Report First Half, 2023 Results on Feb 15, 2023

Capital Allocation Trends At Cochlear (ASX:COH) Aren't Ideal

Upcoming dividend of AU$1.55 per share

Investor sentiment improved over the past week

First half 2022 earnings: EPS and revenues exceed analyst expectations

Cochlear Limited Announces Interim Dividend Expected to Be Payable on 21 April 2022

Estimating The Intrinsic Value Of Cochlear Limited (ASX:COH)

FDA Approves Cochlear Nucleus Implants for Unilateral Hearing Loss/Single-Sided Deafness

Capital Allocation Trends At Cochlear (ASX:COH) Aren't Ideal

Independent Non-Executive Director recently bought AU$56k worth of stock

Cochlear (ASX:COH) Seems To Use Debt Quite Sensibly